Skip to content
Tuesday, November 10, 2026
Pulse Slot 747

Patients Discontinuing Slimming Medications Put On Pounds Far More Rapidly Compared to Dieters

Illustration of pharmaceutical syringe and scale
Obesity treatment involves ongoing approaches.

New research indicates that patients who come off new GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who halt traditional lifestyle programs.

Published data in a leading health publication shows that while overweight individuals frequently drop a large proportion of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"Users using such treatments should be aware of the danger of rapid rebound weight gain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.

Such speed of regain means a reversion to original weight in about a year and a half.

Weighing Therapies

The analysis, which examined 37 of trials involving over 9,000 of patients, contrasted the results of the injectable medications with older methods.

The team note that people who shed pounds through diet and exercise generally experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.

Understanding the Rapid Rebound

Nutrition scientists propose the way of the jabs explains the accelerated regain.

The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement leads to appetite is uncontrolled, making binge eating a significant risk."

A Lifelong Disease?

Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals say that, considering the likelihood of weight regain, the therapy is often ongoing.

This perspective is echoed by pharmaceutical companies, who state that the findings "emphasize the chronic nature of obesity," comparing it to managing diseases like hypertension.

User Testimonies

People who have stopped the jabs explain a powerful resurgence of appetite.

"It felt as if a switch flipping and you're instantly ravenous," described a patient.

This difficulty is compounded if individuals have not established sustainable dietary or behavioural modifications during treatment.

Growing Adoption

Survey data indicate that millions of adults in the UK have tried these injections in the past year, with interest being substantial.

  • Use is higher among women than men.
  • The 40s and 50s age group shows the greatest level of interest.
  • Many access the drugs through private healthcare rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are potent tools for shedding pounds, they are not a magic fix and maintained weight loss likely depends on integrated behavioural management.

By

Christopher Bryant

A seasoned gaming analyst with over a decade of experience in casino strategy and game development.

Pulse Slot 747

Type to search articles.